Pasithea Therapeutics (KTTA) said Thursday that interim data from a phase 1 study showed that its experimental drug, PAS-004, was effective and safe in treating neurofibromatosis type 1 and other cancer indications.

Shares surged more than 47% as intraday trading volume climbed to more than 53 million from a daily average of under 18,000.

Telesis Bio (TBIO) disclosed a partnership with Beckman Coulter Life Sciences late Wednesday to set up scalable bio-foundries to deliver on-premise DNA synthesis.

Shares jumped 40% in recent trading Thursday as intraday trading volume soared to over 23.2 million from a daily average of nearly 1.1 million.

Micron Technology (MU) late Wednesday swung to a bigger-than-expected profit for fiscal Q4 as mounting demand for artificial intelligence propelled the memory and storage product maker's revenue above Wall Street's estimates.

Shares climbed more than 13% Thursday, with intraday trading volume at over 83.8 million compared with a daily average of about 24.3 million.

Price: 5.68, Change: +1.83, Percent Change: +47.70